Gambogic Acid Sensitizes Ovarian Cancer Cells to Doxorubicin Through ROS-Mediated Apoptosis

[1]  A. C. Uguz,et al.  Melatonin potentiates chemotherapy‐induced cytotoxicity and apoptosis in rat pancreatic tumor cells , 2012, Journal of pineal research.

[2]  Jia Wei,et al.  Enhancement of anticancer efficacy of chemotherapeutics by gambogic acid against gastric cancer cells. , 2012, Cancer biotherapy & radiopharmaceuticals.

[3]  F. Pinguet,et al.  Intraperitoneal administration of novel doxorubicin loaded polymeric delivery systems against peritoneal carcinomatosis: experimental study in a murine model of ovarian cancer. , 2011, Gynecologic oncology.

[4]  R. Coleman,et al.  Management Strategies for Recurrent Platinum-Resistant Ovarian Cancer , 2011, Drugs.

[5]  Richard G. Moore,et al.  Tetrathiomolybdate induces doxorubicin sensitivity in resistant tumor cell lines. , 2011, Gynecologic oncology.

[6]  B. Aggarwal,et al.  Gambogic Acid Inhibits STAT3 Phosphorylation through Activation of Protein Tyrosine Phosphatase SHP-1: Potential Role in Proliferation and Apoptosis , 2011, Cancer Prevention Research.

[7]  L. Juillerat-Jeanneret,et al.  Drug combinations with quercetin: doxorubicin plus quercetin in human breast cancer cells , 2011, Cancer Chemotherapy and Pharmacology.

[8]  Di Chen,et al.  Gambogic acid enhances proteasome inhibitor-induced anticancer activity. , 2011, Cancer letters.

[9]  R. Hu,et al.  Gambogic acid triggers DNA damage signaling that induces p53/p21(Waf1/CIP1) activation through the ATR-Chk1 pathway. , 2010, Cancer letters.

[10]  P. Dent,et al.  Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction , 2010, Proceedings of the National Academy of Sciences.

[11]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[12]  M. Fukuoka,et al.  Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugs , 2010, British Journal of Cancer.

[13]  J. K. Kundu,et al.  Resveratrol suppresses growth of human ovarian cancer cells in culture and in a murine xenograft model: eukaryotic elongation factor 1A2 as a potential target. , 2009, Cancer research.

[14]  Cristina Carvalho,et al.  Doxorubicin: the good, the bad and the ugly effect. , 2009, Current medicinal chemistry.

[15]  Yan Chen,et al.  Gambogic acid induces G0/G1 arrest and apoptosis involving inhibition of SRC-3 and inactivation of Akt pathway in K562 leukemia cells. , 2009, Toxicology.

[16]  Jie Zhao,et al.  Gambogic acid reduced bcl-2 expression via p53 in human breast MCF-7 cancer cells , 2009, Journal of Cancer Research and Clinical Oncology.

[17]  Peng Huang,et al.  Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? , 2009, Nature Reviews Drug Discovery.

[18]  Yong Yang,et al.  Reactive oxygen species accumulation contributes to gambogic acid-induced apoptosis in human hepatoma SMMC-7721 cells. , 2009, Toxicology.

[19]  Qing Zhao,et al.  Synergistic effect of 5-fluorouracil with gambogic acid on BGC-823 human gastric carcinoma. , 2009, Toxicology.

[20]  J. Tao,et al.  Gambogic acid induces apoptosis by regulating the expression of Bax and Bcl‐2 and enhancing caspase‐3 activity in human malignant melanoma A375 cells , 2009, International journal of dermatology.

[21]  Jie Zhao,et al.  Gambogic acid mediates apoptosis as a p53 inducer through down-regulation of mdm2 in wild-type p53-expressing cancer cells , 2008, Molecular Cancer Therapeutics.

[22]  Yong Yang,et al.  Microtubule depolymerization and phosphorylation of c-Jun N-terminal kinase-1 and p38 were involved in gambogic acid induced cell cycle arrest and apoptosis in human breast carcinoma MCF-7 cells. , 2008, Life sciences.

[23]  Jia Wei,et al.  Gambogic acid, a potent inhibitor of survivin, reverses docetaxel resistance in gastric cancer cells. , 2008, Cancer letters.

[24]  Mingyao Liu,et al.  Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling. , 2008, Cancer research.

[25]  Anil K Sood,et al.  Early events in the pathogenesis of epithelial ovarian cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  B. Aggarwal,et al.  Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-kappaB signaling pathway. , 2007, Blood.

[27]  Yong Yang,et al.  Differential apoptotic induction of gambogic acid, a novel anticancer natural product, on hepatoma cells and normal hepatocytes. , 2007, Cancer letters.

[28]  A. Panthong,et al.  Anti-inflammatory, analgesic and antipyretic activities of the extract of gamboge from Garcinia hanburyi Hook f. , 2007, Journal of ethnopharmacology.

[29]  L. Ding,et al.  Determination of gambogic acid in human plasma by liquid chromatography-atmospheric pressure chemical ionization-mass spectrometry. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[30]  Hai-wei Zhang,et al.  Gambogic acid-induced G2/M phase cell-cycle arrest via disturbing CDK7-mediated phosphorylation of CDC2/p34 in human gastric carcinoma BGC-823 cells. , 2006, Carcinogenesis.

[31]  Q. Qi,et al.  Toxicological studies of gambogic acid and its potential targets in experimental animals. , 2006, Basic & clinical pharmacology & toxicology.

[32]  A. Nudelman,et al.  Doxorubicin-DNA adducts induce a non-topoisomerase II-mediated form of cell death. , 2006, Cancer research.

[33]  Li Zhao,et al.  Anticancer effect and apoptosis induction of gambogic acid in human gastric cancer line BGC-823. , 2005, World journal of gastroenterology.

[34]  R. Ozols.  Treatment goals in ovarian cancer , 2005, International Journal of Gynecologic Cancer.

[35]  H. Hosoi,et al.  Fenretinide induces sustained‐activation of JNK/p38 MAPK and apoptosis in a reactive oxygen species‐dependent manner in neuroblastoma cells , 2004, International journal of cancer.

[36]  E. Kohn,et al.  Proteomics and ovarian cancer: implications for diagnosis and treatment: a critical review of the recent literature , 2004, Current opinion in oncology.

[37]  Q. You,et al.  Gambogic acid induces apoptosis and regulates expressions of Bax and Bcl-2 protein in human gastric carcinoma MGC-803 cells. , 2004, Biological & pharmaceutical bulletin.

[38]  Q. You,et al.  General gambogic acids inhibited growth of human hepatoma SMMC-7721 cells in vitro and in nude mice. , 2004, Acta pharmacologica Sinica.

[39]  S. Kasibhatla,et al.  Discovery, characterization and SAR of gambogic acid as a potent apoptosis inducer by a HTS assay. , 2004, Bioorganic & medicinal chemistry.

[40]  G. Mills,et al.  Sustained Activation of JNK/p38 MAPK Pathways in Response to Cisplatin Leads to Fas Ligand Induction and Cell Death in Ovarian Carcinoma Cells* , 2003, Journal of Biological Chemistry.

[41]  B. Aggarwal,et al.  Chemopreventive Agents Induce Suppression of Nuclear Factor‐κB Leading to Chemosensitization , 2002, Annals of the New York Academy of Sciences.

[42]  R. Berkowitz,et al.  The clinical utility of liposomal doxorubicin in recurrent ovarian cancer. , 2001, Gynecologic oncology.

[43]  B. Fanburg,et al.  Reactive oxygen species in cell signaling. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[44]  D. Gewirtz,et al.  A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. , 1999, Biochemical pharmacology.

[45]  Kohei Miyazono,et al.  Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1 , 1998, The EMBO journal.

[46]  S. Rajagopalan,et al.  Adriamycin activation and oxygen free radical formation in human breast tumor cells: protective role of glutathione peroxidase in adriamycin resistance. , 1989, Cancer research.

[47]  D. Gerlier,et al.  Use of MTT colorimetric assay to measure cell activation. , 1986, Journal of immunological methods.

[48]  Wang Jin-wan.  PhaseIhuman tolerability trial of gambogic acid , 2007 .

[49]  R. Ozols,et al.  Focus on epithelial ovarian cancer. , 2004, Cancer cell.

[50]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[51]  T. Chou,et al.  Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. , 1984, Advances in enzyme regulation.